Inhibitors of the FcRn:IgG Protein–Protein Interaction

Journal Title: The AAPS Journal - Year 2009, Vol 11, Issue 3

Abstract

The neonatal Fc receptor, FcRn, is responsible for controlling the half-life of IgG antibodies. As a result, inhibitors of FcRn have been investigated as a possible way to modulate IgG half-lives. Such inhibitors could have possible applications in reducing autoantibody levels in autoimmune disease states. To date, monoclonal antibodies, engineered Fc domains, and short peptides have been reported to inhibit FcRn function and modulate IgG half-lives in vivo.

Authors and Affiliations

Susan C. Low, Adam R. Mezo

Keywords

Related Articles

Cell-permeable, mitochondrial-targeted, peptide antioxidants

Cellular oxidative injury has been implicated in aging and a wide array of clinical disorders including ischemia-reperfusion injury; neurodegenerative diseases; diabetes; inflammatory diseases such as atherosclerosis, ar...

Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice

An epidemic of asthma fatalities in the 1970s prompted a series of case-control studies which indicated that short acting β-agonists increased the risk of death. Subsequent mechanistic and pharmacodynamic studies...

Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose–Response Models

The online version of this article (doi:10.1208/s12248-012-9349-2) contains supplementary material, which is available to authorized users.

Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation

The physical structure and polymorphism of nimodipine were studied by means of micro-Raman, WAXD, DSC, and SEM for cases of the pure drug and its solid dispersions in PEG 4000, prepared by both the hot-melt and solvent e...

Permeability classification of representative fluoroquinolones by a cell culture method

This study was undertaken to categorize representative fluoroquinolone drug substance permeability based on the methods outlined in the Food and Drug Administration's biopharmaceutic classification system (BCS) Guidance...

Download PDF file
  • EP ID EP681501
  • DOI  10.1208/s12248-009-9120-5
  • Views 45
  • Downloads 0

How To Cite

Susan C. Low, Adam R. Mezo (2009). Inhibitors of the FcRn:IgG Protein–Protein Interaction. The AAPS Journal, 11(3), -. https://europub.co.uk/articles/-A-681501